{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:19:43Z","timestamp":1763558383974,"version":"3.45.0"},"reference-count":92,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The utilisation of cardiopulmonary bypass (CPB) during cardiac surgery is often associated with complex haemostatic perturbations, frequently manifesting as a paradoxical risk of both bleeding and thrombosis. This is postulated to be driven by systemic inflammation, endothelial activation and contact activation of the coagulation cascade due to extracorporeal circulation. However, the coronavirus disease 2019 (COVID-19) pandemic revealed a unique hypercoagulable state, termed COVID-19-associated coagulopathy (CAC), also observed in those vaccinated against COVID-19. CAC displays similar physiological manifestations to those of disseminated intravascular coagulation (DIC), characterised by elevated fibrinogen and D-dimer values. The precise pathogenesis of CAC requires further elucidation though proposed mechanisms include: an exaggerated inflammatory response to COVID-19 infection or antibody proliferation due to vaccination, direct epithelial cell damage mediated by angiotensin converting enzyme 2, and \u2018hypoxithrombosis\u2019. CAC has since provided a unique framework to understand and potentially mitigate coagulation complications encountered during CPB in the post-pandemic era, as it is no longer sufficient to view COVID-19 as a transient influence on surgical risk. Rather, it must be recognized as a persistent modifier of the haemostatic environment across the population, with direct implications upon patient selection, intraoperative management and postoperative care in cardiac surgery. This review examines the pathological drivers behind CAC alongside the insights obtained from CAC management during ECMO deployment, to investigate the potential translation of such knowledge into improved anticoagulation strategies and monitoring during cardiac surgery. The use of alternative anticoagulants including factor XI inhibitors and the modulation of heparinase activity offers promising avenues to attenuate coagulopathies more commonly observed during CPB in the post-pandemic climate, whilst anti-Xa assays and viscoelastic testing have offered applicability to modern perfusion practices. By bridging the knowledge gained during the pandemic with that of conventional CPB, this review aims to inform future strategies for haemostasis management in cardiac surgery in a novel cohort of surgical patients.<\/jats:p>","DOI":"10.3390\/jcm14228109","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:55:31Z","timestamp":1763556931000},"page":"8109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Pandemic to Practice: How COVID-19 Has Reshaped Haemostasis in Cardiac Surgery: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8466-7149","authenticated-orcid":false,"given":"Lydia","family":"Wilkinson","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford University Hospital NHS Trust, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arian","family":"Arjomandi Rad","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford University Hospital NHS Trust, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Oliver","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford University Hospital NHS Trust, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Kourliouros","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford University Hospital NHS Trust, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.eclinm.2020.100639","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis","volume":"29","author":"Malas","year":"2020","journal-title":"EClinicalMedicine."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/jth.15490","article-title":"Persistent endotheliopathy in the pathogenesis of long COVID syndrome","volume":"19","author":"Fogarty","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"n2195","DOI":"10.1136\/bmj.n2195","article-title":"Vaccine-induced immune thrombocytopenia and thrombosis: Summary of NICE guidance","volume":"375","author":"Pavord","year":"2021","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1010-7940(01)01099-5","article-title":"Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment","volume":"21","author":"Paparella","year":"2002","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_11","first-page":"353","article-title":"Coagulopathy in COVID-19: Clinical and laboratory manifestations, challenges, and lessons learned","volume":"59","author":"Favaloro","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","article-title":"COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","volume":"40","author":"Beyerstedt","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40560-024-00726-2","article-title":"Hemorrhage and thrombosis in COVID-19-patients supported with extracorporeal membrane oxygenation: An international study based on the COVID-19 critical care consortium","volume":"12","author":"Feth","year":"2024","journal-title":"J. Intensive Care"},{"key":"ref_19","first-page":"512","article-title":"Delayed heparin therapy and risk of thrombosis in severe COVID-19 patients on ECMO support","volume":"24","author":"Helms","year":"2020","journal-title":"Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit. Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"de Laat, B., Stragier, H., de Laat-Kremers, R., Ninivaggi, M., Mesotten, D., Thiessen, S., Van Pelt, K., Roest, M., Penders, J., and Vanelderen, P. (2022). Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.966028"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2439627","DOI":"10.1080\/21645515.2024.2439627","article-title":"Hemostatic changes following COVID-19 vaccination: Do they promote a pro-thrombotic state?","volume":"21","author":"Rungjirajittranon","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","article-title":"Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"224","author":"Peluso","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_30","first-page":"100345","article-title":"The BNT162b2 mRNA vaccine induces transient and long-lasting innate immune responses","volume":"2","author":"Geckin","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ostrowski, S.R., S\u00f8gaard, O.S., Tolstrup, M., St\u00e6rke, N.B., Lundgren, J., \u00d8stergaard, L., and Hvas, A.-M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.779453"},{"key":"ref_32","first-page":"121","article-title":"Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies","volume":"63","author":"Wan","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"ref_33","first-page":"95","article-title":"Lung injury after cardiopulmonary bypass: Evidence of a role for complement and endotoxin","volume":"16","author":"Asimakopoulos","year":"1999","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_34","first-page":"2377","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"9","author":"Maas","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.2008.01191.x","article-title":"Contact factor deficiencies and cardiopulmonary bypass surgery: Detection of the defect and monitoring of heparin","volume":"82","author":"Laidlaw","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ozolina, A., Strike, E., Jaunalksne, I., Krumina, A., Bjertnaes, L.J., and Vanags, I. (2012). PAI-1 and t-PA\/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass. BMC Anesthesiol., 12.","DOI":"10.1186\/1471-2253-12-27"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant patterof patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"Ranucci","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1213\/ANE.0000000000002613","article-title":"The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines\u2014Anticoagulation During Cardiopulmonary Bypass","volume":"126","author":"Baker","year":"2018","journal-title":"Anesth. Analg."},{"key":"ref_39","first-page":"e138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Yu","year":"2020","journal-title":"JCI Insight"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"ivac123","DOI":"10.1093\/icvts\/ivac123","article-title":"Effects of cardiopulmonary bypass on immunoglobulin G antibody titres after SARS-CoV-2 vaccination","volume":"35","author":"Hayashi","year":"2022","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e029406","DOI":"10.1161\/JAHA.123.029406","article-title":"Effect of cardiopulmonary bypass on SARS-CoV-2 vaccination antibody levels","volume":"12","author":"Strobel","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Samavati, L., and Uhal, B.D. (2020). ACE2, much more than just a receptor for SARS-CoV-2. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00317"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s43042-022-00314-9","article-title":"Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: From structure\/function to therapeutic implication","volume":"23","author":"Pouremamali","year":"2022","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/VHRM.S299357","article-title":"COVID-19 sepsis: Pathogenesis and endothelial molecular mechanisms based on \u201ctwo-path unifying theory\u201d of hemostasis and endotheliopathy-associated vascular microthrombotic disease","volume":"17","author":"Chang","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1111\/jth.14992","article-title":"Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis","volume":"18","author":"Santoliquido","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neurol.2016.11.004","article-title":"Cerebral venous thrombosis at high altitude: A systematic review","volume":"173","author":"Zavanone","year":"2017","journal-title":"Rev. Neurol."},{"key":"ref_48","first-page":"173","article-title":"Hypoxia-inducible factors and coagulation: Crosstalk in thromboinflammation","volume":"213","author":"Gupta","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_49","first-page":"255","article-title":"Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism\u2014The Troms\u00f8 Study","volume":"5","author":"Evensen","year":"2011","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Reignier","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_52","first-page":"170","article-title":"Heparanase induces tissue factor expression in vascular endothelial and cancer cells","volume":"8","author":"Nadir","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_53","first-page":"255","article-title":"Hypoxia activates heparanase expression in an NF-\u03baB dependent manner","volume":"23","author":"Wu","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Sekulovski, M., Mileva, N., Vasilev, G.V., Miteva, D., Gulinac, M., Peshevska-Sekulovska, M., Chervenkov, L., Batselova, H., Vasilev, G.H., and Tomov, L. (2023). Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102813"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/17534259211051364","article-title":"TLRs in COVID-19: How they drive immunopathology and the rationale for modulation","volume":"27","author":"Mabrey","year":"2021","journal-title":"Innate Immun."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mantovani, S., Oliviero, B., Varchetta, S., Renieri, A., and Mondelli, M.U. (2023). TLRs: Innate immune sentries against SARS-CoV-2 infection. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098065"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Abdelouahed, M., Yateem, D., and Fredericks, S. (2023). Fc\u03b3RIIa-dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1282637"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/bloodadvances.2021005050","article-title":"SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia","volume":"6","author":"Appelbaum","year":"2022","journal-title":"Blood Adv."},{"key":"ref_60","first-page":"7","article-title":"Understanding mechanisms of thrombosis and thrombocytopenia with adenoviral SARS-CoV-2 vaccines: A comprehensive synopsis","volume":"12","author":"Nicolson","year":"2025","journal-title":"Health Technol. Assess."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40560-023-00654-7","article-title":"Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: A narrative review","volume":"11","author":"Alessandri","year":"2023","journal-title":"J. Intensive Care"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"ezae354","DOI":"10.1093\/ejcts\/ezae354","article-title":"EACTS\/EACTAIC\/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"67","author":"Wahba","year":"2024","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_64","unstructured":"International Perfusion Association Goal-Directed Perfusion Working Group (2024). Intraoperative Goal-Directed Perfusion in Cardiac Surgery: Consensus and Practice Update. Perfusion, 39, 123\u2013134."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chiari, P., and Fellahi, J.-L. (2024). Myocardial protection and perfusion management in cardiac surgery: Contemporary strategies and future directions for DO2 optimisation. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1424188"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13019-025-03353-6","article-title":"Monitoring of perioperative tissue perfusion and impact on patient outcomes: Implications for perfusion strategies and DO2-guided management","volume":"20","author":"Li","year":"2025","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40262-025-01496-2","article-title":"Population pharmacokinetic modelling of remdesivir and its metabolite GS-441524 in hospitalised patients with COVID-19","volume":"64","author":"Roberts","year":"2025","journal-title":"Clin. Pharmacokinet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"603","DOI":"10.21608\/asmj.2024.311922.1296","article-title":"Incidence of heparin resistance during cardiopulmonary bypass in adult cardiac surgery in the era of COVID-19","volume":"75","author":"Elsayegh","year":"2024","journal-title":"Ain Shams Med. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1089253220966515","article-title":"Surgical revascularization with cardiopulmonary bypass in a patient with severe COVID-19: Perioperative challenges","volume":"25","author":"Montandrau","year":"2021","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"key":"ref_70","first-page":"54","article-title":"Perfusion strategies for bivalirudin anticoagulation: AIIMS protocol","volume":"6","author":"Sharma","year":"2022","journal-title":"J. Card. Crit. Care"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Navaei, A., Kostousov, V., and Teruya, J. (2023). Is it time to switch to bivalirudin for ECMO anticoagulation?. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1237601"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Schiavoni, L., Mattei, A., Cuccarelli, M., Strumia, A., Dominici, C., Nenna, A., Aceto, J., Palazzo, G., Pascarella, G., and Costa, F. (2024). Argatroban as rescue therapy in heparin-associated thrombocytopenia during ECMO in COVID-19 patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226984"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.113.002332","article-title":"Management and outcomes of major bleeding during treatment with dabigatran or warfarin","volume":"128","author":"Majeed","year":"2013","journal-title":"Circulation"},{"key":"ref_75","first-page":"158","article-title":"Reduced incidence of ischemic stroke in patients with severe factor XI deficiency","volume":"358","author":"Salomon","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/ATVBAHA.107.155952","article-title":"Intrinsic pathway of coagulation and arterial thrombosis","volume":"27","author":"Gailani","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_77","first-page":"115719","article-title":"Discovery of potent and selective factor XIa inhibitors incorporating triazole-based benzoic acid as novel P2\u2032 fragments","volume":"262","author":"Zhuang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_78","unstructured":"ClinicalTrials.gov (2025, November 12). COVID-ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients. ClinicalTrials.gov Identifier: NCT05040776. Updated 2023, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05040776."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood.V108.11.1626.1626","article-title":"Inhibition of heparinase I by defibrotide with potential clinical implications","volume":"108","author":"Fareed","year":"2006","journal-title":"Blood"},{"key":"ref_80","first-page":"477","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: Results of a pivotal Phase II\/III trial","volume":"178","author":"Richardson","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_81","first-page":"100781","article-title":"Heparanase blockade suppresses SARS-CoV-2 infectivity and cytokine release from macrophages","volume":"3","author":"Xiang","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13019-022-01862-2","article-title":"Accuracy of point-of-care coagulation testing during cardiopulmonary bypass in a patient post COVID-19 infection","volume":"17","author":"Grewal","year":"2022","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_83","first-page":"846","article-title":"Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation in patients infected with COVID-19","volume":"189","author":"Hunt","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_84","first-page":"A2957","article-title":"Comparisons of TEG versus standard heparin monitoring assays in COVID-19 positive VV-ECMO","volume":"205","author":"Stradleigh","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/02676591211024090","article-title":"Anticoagulation monitoring in extracorporeal membrane oxygenation","volume":"36","author":"Hou","year":"2021","journal-title":"Perfusion"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0267659120952982","article-title":"Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"36","author":"Willems","year":"2020","journal-title":"Perfusion"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0885066621997039","article-title":"Association of D-dimer and fibrinogen with hypercoagulability assessed by thromboelastography in critically ill COVID-19 patients","volume":"36","author":"Chandel","year":"2021","journal-title":"J. Intensive Care Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2020008762","article-title":"Antibody-induced procoagulant platelets in severe COVID-19 infection","volume":"137","author":"Althaus","year":"2021","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s10020-021-00412-1","article-title":"Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19","volume":"27","author":"Zhang","year":"2021","journal-title":"Mol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Maldonado, F., Morales, D., D\u00edaz-Papapietro, C., Vald\u00e9s, C., Fernandez, C., Valls, N., Lazo, M., Espinoza, C., Gonz\u00e1lez, R., and Guti\u00e9rrez, R. (2022). Relationship between endothelial and angiogenesis biomarkers envisages mortality in a prospective cohort of COVID-19 patients requiring respiratory support. Front. Med., 9.","DOI":"10.3389\/fmed.2022.826218"},{"key":"ref_92","first-page":"e0194","article-title":"Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: Implications for microvascular platelet aggregation","volume":"2","author":"Fraser","year":"2020","journal-title":"Crit. Care Explor."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/8109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:16:26Z","timestamp":1763558186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/8109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":92,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14228109"],"URL":"https:\/\/doi.org\/10.3390\/jcm14228109","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,11,16]]}}}